Sign in to view content

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting

Marko Lukic, MD PhD FEBO FASRS

Video
Published 2019

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Diabetic Retinopathy and the MyVisionTrack App Study (DRAMA)
Samuel K. Steven Houston, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Progression to Pars Plana Vitrectomy After Monotherapy With Panretinal Photocoagulation or Anti-VEGF injections in Proliferative Diabetic Retinopathy
Karen M Wai, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more